• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞的神经保护作用。

Neuroprotective features of mesenchymal stem cells.

机构信息

Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Via De Toni 5, 16132 Genoa, Italy.

出版信息

Best Pract Res Clin Haematol. 2011 Mar;24(1):59-64. doi: 10.1016/j.beha.2011.01.004. Epub 2011 Feb 25.

DOI:10.1016/j.beha.2011.01.004
PMID:21396593
Abstract

Bone marrow (BM) derived mesenchymal stem cells (MSC) differentiate into cells of the mesodermal lineage but also, under certain experimental circumstances, into cells of the neuronal and glial lineage. Their therapeutic translation has been significantly boosted by the demonstration that MSC display significant also anti-proliferative, anti-inflammatory and anti-apoptotic features. These properties have been exploited in the effective treatment of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis where the inhibition of the autoimmune response resulted in a significant neuroprotection. A significant rescue of neural cells has been achieved also when MSC were administered in experimental brain ischemia and in animals undergoing brain or spinal cord injury. In these experimental conditions BM-MSC therapeutic effects are likely to depend on paracrine mechanisms mediated by the release of growth factors, anti-apoptotic molecules and anti-inflammatory cytokines creating a favorable environment for the regeneration of neurons, remyelination and improvement of cerebral flow. For potential clinical application BM-MSC offer significant practical advantages over other types of stem cells since they can be obtained from the adult BM and can be easily cultured and expanded in vitro under GMP conditions displaying a very low risk of malignant transformation. This review discusses the targets and mechanisms of BM-MSC mediated neuroprotection.

摘要

骨髓(BM)来源的间充质干细胞(MSC)可分化为中胚层谱系的细胞,但在某些实验条件下,也可分化为神经元和神经胶质谱系的细胞。MSC 表现出显著的抗增殖、抗炎和抗凋亡特性,这一发现极大地推动了它们的治疗转化。这些特性已在实验性自身免疫性脑脊髓炎(EAE)的有效治疗中得到了利用,EAE 是多发性硬化症的动物模型,其中自身免疫反应的抑制导致了显著的神经保护。当 MSC 用于实验性脑缺血和脑或脊髓损伤动物时,也实现了对神经细胞的显著挽救。在这些实验条件下,BM-MSC 的治疗效果可能取决于旁分泌机制,这些机制是通过释放生长因子、抗凋亡分子和抗炎细胞因子介导的,从而为神经元的再生、髓鞘形成和脑血流改善创造有利的环境。对于潜在的临床应用,BM-MSC 比其他类型的干细胞具有显著的实际优势,因为它们可以从成人 BM 中获得,并且可以在 GMP 条件下在体外容易地培养和扩增,具有非常低的恶性转化风险。本综述讨论了 BM-MSC 介导的神经保护的靶点和机制。

相似文献

1
Neuroprotective features of mesenchymal stem cells.间充质干细胞的神经保护作用。
Best Pract Res Clin Haematol. 2011 Mar;24(1):59-64. doi: 10.1016/j.beha.2011.01.004. Epub 2011 Feb 25.
2
Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.间充质干细胞在慢性实验性自身免疫性脑脊髓炎中的神经保护和免疫调节作用
Arch Neurol. 2008 Jun;65(6):753-61. doi: 10.1001/archneur.65.6.753.
3
Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.间充质骨髓干细胞(MSCs)的免疫调节与神经保护作用:一种针对多发性硬化症及其他神经免疫/神经退行性疾病的潜在治疗方法。
J Neurol Sci. 2008 Feb 15;265(1-2):131-5. doi: 10.1016/j.jns.2007.05.005. Epub 2007 Jul 3.
4
Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis.实验性自身免疫性脑脊髓炎中自体骨髓间充质干细胞移植的可变行为和并发症。
Exp Neurol. 2011 Jul;230(1):78-89. doi: 10.1016/j.expneurol.2011.02.021. Epub 2011 Apr 5.
5
Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.间充质干细胞中睫状神经营养因子的过表达可减少实验性自身免疫性脑脊髓炎小鼠的脱髓鞘并诱导临床恢复。
J Neuroimmunol. 2009 Jan 3;206(1-2):58-69. doi: 10.1016/j.jneuroim.2008.10.014. Epub 2008 Dec 9.
6
Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.同种异体注射胎膜来源的间充质干细胞可在大鼠后肢缺血模型中诱导治疗性血管生成。
Stem Cells. 2008 Oct;26(10):2625-33. doi: 10.1634/stemcells.2008-0236. Epub 2008 Jul 31.
7
Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis.鞘内注射间充质干细胞源性神经前体细胞对实验性多发性硬化模型的临床和病理影响。
J Neurol Sci. 2012 Feb 15;313(1-2):167-77. doi: 10.1016/j.jns.2011.08.036. Epub 2011 Oct 1.
8
Autoreactive T cells induce in vitro BM mesenchymal stem cell transdifferentiation to neural stem cells.自身反应性T细胞在体外诱导骨髓间充质干细胞转分化为神经干细胞。
Cytotherapy. 2006;8(3):196-201. doi: 10.1080/14653240600735958.
9
Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration.骨髓间充质干细胞治疗新生鼠缺氧缺血性脑损伤可改善行为学预后,并促进神经元和少突胶质细胞再生。
Brain Behav Immun. 2010 Mar;24(3):387-93. doi: 10.1016/j.bbi.2009.10.017. Epub 2009 Oct 31.
10
Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.体外扩增自体骨髓间充质基质细胞治疗人类脊髓损伤/截瘫:一项初步临床研究。
Cytotherapy. 2009;11(7):897-911. doi: 10.3109/14653240903253857.

引用本文的文献

1
Intranasal administration of stem cell derivatives for the treatment of AD animal models: a systematic review and meta-analysis.经鼻给药干细胞衍生物治疗AD动物模型:一项系统评价和荟萃分析。
Stem Cell Res Ther. 2025 Jul 28;16(1):409. doi: 10.1186/s13287-025-04555-4.
2
Age-Related Neurodegenerative Diseases: A Stem Cell's Perspective.年龄相关性神经退行性疾病:干细胞视角
Cells. 2025 Feb 27;14(5):347. doi: 10.3390/cells14050347.
3
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases.将线粒体生物学融入神经退行性疾病的创新细胞疗法
Brain Sci. 2024 Sep 5;14(9):899. doi: 10.3390/brainsci14090899.
4
Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics.光生物调节疗法对大脑的影响:开创革新方法,改变认知动态。
Cells. 2024 Jun 3;13(11):966. doi: 10.3390/cells13110966.
5
Human dental pulp stem cells mitigate the neuropathology and cognitive decline via AKT-GSK3β-Nrf2 pathways in Alzheimer's disease.人牙髓间充质干细胞通过 AKT-GSK3β-Nrf2 通路减轻阿尔茨海默病的神经病理学和认知衰退。
Int J Oral Sci. 2024 May 13;16(1):40. doi: 10.1038/s41368-024-00300-4.
6
Human Mesenchymal Stem Cell Transplantation Improved Functional Outcomes Following Spinal Cord Injury Concomitantly with Neuroblast Regeneration.人骨髓间充质干细胞移植改善脊髓损伤后的功能结局并伴有神经母细胞再生。
Adv Pharm Bull. 2023 Nov;13(4):806-816. doi: 10.34172/apb.2023.058. Epub 2022 Oct 20.
7
Unveiling Mesenchymal Stem Cells' Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications.揭示间充质干细胞在临床应用中的再生潜力:miRNA 和 lncRNA 作用的新见解。
Cells. 2023 Oct 31;12(21):2559. doi: 10.3390/cells12212559.
8
Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer's disease.经鼻给予诱导多能干细胞衍生的皮质神经干细胞 secretome 作为阿尔茨海默病的治疗选择。
Transl Neurodegener. 2023 Nov 9;12(1):50. doi: 10.1186/s40035-023-00384-8.
9
Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy.玻璃体内同种异体间充质干细胞治疗急性非动脉炎性前部缺血性视神经病变的 II 期非随机临床试验。
Stem Cell Res Ther. 2023 Sep 21;14(1):261. doi: 10.1186/s13287-023-03500-7.
10
Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects.基于多能间充质干细胞的脊髓损伤治疗:当前进展与未来展望
Biology (Basel). 2023 Apr 26;12(5):653. doi: 10.3390/biology12050653.